½ÅÃ̼¼ºê¶õ½ºº´¿ø 2022 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãß°è½ÉÆ÷Áö¾ö : 2022-11-27±³À°ÀÏÀÚ : 2022-11-27
±³À°Àå¼Ò : ½ÅÃ̼¼ºê¶õ½ºº´¿ø ¿¡ºñ½¼ÀÇ»ý¸í¿¬±¸¼¾ÅÍ À¯ÀÏÇÑȦ
±³À°ÁÖÁ¦ :
2022 ´ëÇѳ»ºÐºñ¿Ü°úÇÐȸ Ãß°è½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±³»ºÐºñ¿Ü°úÇÐȸ
´ã´çÀÚ : ±èÀº¿µ
¿¬¶ôó : 02-501-2988
À̸ÞÀÏ :
kates1996@naver.com ±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í [»çÀüµî·Ï] Á¤È¸¿ø(Àü¹®ÀÇ):50,000¿ø/ºñȸ¿ø: 60,000¿ø/ÁØȸ¿ø(Àü°øÀÇ ¹× °£È£»ç): 30,000¿ø[ÇöÀåµî·Ï] Á¤È¸¿ø(Àü¹®ÀÇ):70,000¿ø/ºñȸ¿ø: 80,000¿ø/ÁØȸ¿ø(Àü°øÀÇ ¹× °£È£»ç): 50,000¿ø* 65¼¼ÀÌ»ó ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11-27 À¯ÀÏÇÑȦ 09:00~09:05 °³È¸»ç Á¤Á¾±æ(¿©¼öÀü³²º´¿ø)
±âŸ 11-27 À¯ÀÏÇÑȦ 09:05~09:10 ÇÁ·Î±×·¥ ¼Ò°³ À±ÇöÁ¶(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 09:10~09:30 2021 Korean TIRADS(Thyroid Imaging Reporting and Data System) ÇÏÀºÁÖ(¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 09:30~09:50 2022 WHO Classification of Thyroid Neopla ¿øÀç°æ(¼¿ïÀÇ´ë º´¸®°ú)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 09:50~10:10 2022 KTA °©»ó¼± °áÀý Áø·á±Ç°í¾È ÀÌÀº°æ(±¹¸³¾Ï¼¾ÅÍ ³»°ú)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 10:10~10:30 2022 KTA ÀӽŰú °©»ó¼±Áúȯ Áø·á±Ç°í¾È ÃÖÇý·Ã(À»ÁöÀÇ´ë)
ÈÞ½Ä 11-27 10:30~10:50 Coffee Break ()
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 10:50~11:10 Histopathological and molecular biology ¼Ûµ¿Àº(¿ï»êÀÇ´ë º´¸®°ú)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 11:10~11:30 Role of imaging ³ë¹Ì¸®ºñ(¿¬¼¼ÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 11:30~11:50 Therapeutic strategy ±è¼ö¿µ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 11:50~12:10 ¿©Æ÷¼º Á¾¾çȯÀÚÀÇ ¿¹ÈÄ ±è¹ÌÁø(ºÎ»êÀÇ´ë ³»°ú)
½Ä»ç 11-27 12:10~13:00 Lunch ()
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 13:00~13:20 Surgery À¯Çü¿ø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 13:20~13:40 RFA(Radiofrequency ablation) ¼ºÁø¿ë(´ë¸²¼º¸ðº´¿ø ¿µ»óÀÇÇаú)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 13:40~14:00 Laser ablation ±èÈ£Áø(¶óÆÄ¿¤º´¿ø)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 14:00~14:20 Å©±â°¡ Å« ¾ç¼º Á¾¾çȯÀÚÀÇ º¸Á¸ÀûÄ¡·á È«ÁØÈ(À»ÁöÀÇ´ë ³»°ú)
ÈÞ½Ä 11-27 14:20~14:40 Coffee Break ()
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 14:40~15:00 Oncogenes and tumor suppressor genes in thyroid nodules and nonmedullary thyroid cancer Á¤Âù±Ç(°¡Å縯ÀÇ´ë º´¸®°ú)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 15:00~15:20 Application of molecular test in clinical ting ±è¿ø±¸(¿ï»êÀÇ´ë ³»°ú)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 15:20~15:40 Surgical approach to thyroid cancer informed by molecular testing ±è¼®¸ð(¿¬¼¼ÀÇ´ë ³»°ú)
±³À°½Ã°£ 11-27 À¯ÀÏÇÑȦ 15:40~16:00 Medical treatment based on molecular testing in advanced thyroid cancer ¹Ú¿µÁÖ(¼¿ïÀÇ´ë ³»°ú)